Cargando…
Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients
Naturally occurring resistance-associated substitutions (RASs) can negatively impact the response to direct-acting antivirals (DAAs) agents-based therapies for hepatitis C virus (HCV) infection. Herein, we set out to characterize the RASs in the HCV1b genome from serum samples of DAA-naïve patients...
Autores principales: | Marascio, Nadia, Pavia, Grazia, Strazzulla, Alessio, Dierckx, Tim, Cuypers, Lize, Vrancken, Bram, Barreca, Giorgio Settimo, Mirante, Teresa, Malanga, Donatella, Oliveira, Duarte Mendes, Vandamme, Anne-Mieke, Torti, Carlo, Liberto, Maria Carla, Focà, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037695/ https://www.ncbi.nlm.nih.gov/pubmed/27618896 http://dx.doi.org/10.3390/ijms17091416 |
Ejemplares similares
-
Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015) -
Update on different aspects of HCV variability: focus on NS5B polymerase
por: Marascio, Nadia, et al.
Publicado: (2014) -
Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
por: Marascio, Nadia, et al.
Publicado: (2019) -
Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?
por: Zicca, Emilia, et al.
Publicado: (2014) -
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals
por: Strazzulla, Alessio, et al.
Publicado: (2014)